Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
GlobeNewswire
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a..
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a..
TORONTO, May 31, 2024 (GLOBE NEWSWIRE) -- *International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm:..
"If you want peace, let's meet at the peace summit. It is absolutely fair that we are preparing this platform together with other..